Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for ...

For the quarter ended March 31, 2025 Net sales of $970.5 million, declined 5.4% sequentially and 26.8% from the year ago ...

King’s College faculty and students hosted dozens of local grade school children Wednesday for fun STEM activities, including ...

Rapport Therapeutics, Inc. RAP-219 Phase 2a trial in patients with refractory focal epilepsy remains on track with topline ...

You might call the Cincinnati Reds' latest win "the Austin Hays game." The Reds took a series-opener from the Seattle Mariners on Tuesday, 8-4 at Great American Ball Park, and Hays enjoyed a ...

The Operating Committees of the Securities Information Processors ("Processors" or "SIPs") today announced that they will soon submit a Plan Amendment to the Securities and Exchange Commission ("SEC") ...